| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/14/2005 | WO2005063771A1 Methods of preparing olanzapine |
| 07/14/2005 | WO2005063742A2 Amidino compounds as cysteine protease inhibitors |
| 07/14/2005 | WO2005063714A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 07/14/2005 | WO2005062882A2 Rifamycin analogs and uses thereof |
| 07/14/2005 | WO2005062748A2 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 07/14/2005 | US20050153989 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050152913 Process for preapring maytansinol |
| 07/14/2005 | CA2551806A1 Methods of preparing olanzapine |
| 07/14/2005 | CA2551611A1 Thiazole derivatives for treating or preventing parkinson's disease |
| 07/14/2005 | CA2550729A1 Rifamycin analogs and uses thereof |
| 07/13/2005 | EP1551849A1 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/13/2005 | EP1551822A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
| 07/13/2005 | EP1551412A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/13/2005 | CN1639165A Purine derivatives as kinase inhibitors |
| 07/13/2005 | CN1638769A Ophthalmic composition comprising ascomycin |
| 07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
| 07/13/2005 | CN1637000A Imidazole ring-containing compound and organic electroluminescence display device |
| 07/13/2005 | CN1636999A Benzobisazole-base compound |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/07/2005 | WO2005061657A1 Single-layer organic el device |
| 07/07/2005 | WO2005061483A2 Modulators of peripheral 5-ht receptors |
| 07/07/2005 | US20050148769 Tricyclic compound having spiro union |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148603 Compositions useful as inhibitors of protein kinases |
| 07/07/2005 | US20050148582 N-[1-butyl-4-piperidinylmethyl[3,4-dihydro-2 oxazino[3,2-a indole-10 carboxamide as drugs with Cahpo4 or Ca3/po4/2 fillers or binders for use in treatment of irritable bowel syndrome, urinry incontience or arrhythmias |
| 07/07/2005 | US20050148578 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148576 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 07/07/2005 | US20050147997 Blocking group(s) is released by reaction with trigger (phosphatase); optionally contains urea-containing group for attaching proteins, peptides or nucleic acids; rhodamine; kits |
| 07/07/2005 | US20050145831 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals |
| 07/06/2005 | EP1550663A1 New crystalline forms of antiarrhythmic compounds |
| 07/06/2005 | EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 07/06/2005 | EP1549626A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1390370A4 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 07/06/2005 | EP1315720B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635889A Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 07/06/2005 | CN1635857A Medical devices containing rapamycin analogs |
| 07/06/2005 | CN1634928A Camptothecin derivatives preparing process |
| 07/05/2005 | US6914140 Asymmetric synthesis process |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 06/30/2005 | WO2005058913A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| 06/30/2005 | WO2005058912A1 Process for preparing amide acetals |
| 06/30/2005 | WO2005058911A2 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
| 06/30/2005 | WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics |
| 06/30/2005 | WO2005058327A1 Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists |
| 06/30/2005 | WO2005058318A1 3-cyano-quinoline derivatives with antiproliferative activity |
| 06/30/2005 | WO2005058231A2 Rifamycin analogs and uses thereof |
| 06/30/2005 | WO2005035533A8 Modulators of serotonin receptors |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143421 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy |
| 06/30/2005 | US20050143382 Heterocyclic compounds as pharmaceutically active compounds |
| 06/30/2005 | US20050143374 Antimicrobial agents and uses thereof |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143338 1-(2,5'-Anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3 deoxynucleotides |
| 06/30/2005 | CA2549869A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| 06/30/2005 | CA2549728A1 3-cyano-quinoline derivatives with antiproliferative activity |
| 06/30/2005 | CA2549001A1 Rifamycin analogs and uses thereof |
| 06/30/2005 | CA2547519A1 Process for preparing amide acetals |
| 06/29/2005 | EP1546369A2 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 06/29/2005 | EP1546151A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| 06/29/2005 | EP1546150A1 Biologically active compounds |
| 06/29/2005 | EP1545545A2 COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS |
| 06/29/2005 | EP1545453A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/29/2005 | EP1359917B1 Thioxazinoquinolones useful for the treatment of viral infections |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/28/2005 | US6911452 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 06/28/2005 | US6911445 For reatment of depression, childhood depression, dysthymia, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive-compulsive disorder, cocaine and alcohol addiction |
| 06/28/2005 | US6911442 Has no toxicological effects; adapted for oral, topical or parenteral use and may be used for the treatment of bacterial infection in mammals |
| 06/23/2005 | US20050137401 Process for the preparation of tetrahydrothieno [3,2-C] pyridine derivatives |
| 06/23/2005 | US20050137189 For therapy of Gram-positive bacterial infection |
| 06/22/2005 | EP1542674A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 06/22/2005 | EP1350794B1 Process for preparing substance gm-95 |
| 06/22/2005 | EP1268466B1 Decahydro-isoquinolines |
| 06/22/2005 | CN1630655A Dual action antibiotics |
| 06/22/2005 | CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 06/21/2005 | US6908932 Modulators of phosphoinositide 3-kinase |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/16/2005 | WO2005054253A1 Process for the purification of macrolides |
| 06/16/2005 | WO2005054242A1 Muscarinic agents as therapeutic compounds |
| 06/16/2005 | WO2005054234A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
| 06/16/2005 | WO2005026145A3 Quinolone antibacterial agents |
| 06/16/2005 | WO2005025293A3 Fused ring heterocycles as potassium channel modulators |
| 06/16/2005 | WO2005007658A3 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 06/16/2005 | US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents |
| 06/16/2005 | US20050131164 Dehydration mixture of oxyamides; reacting acid or ester with dialkanolamine |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131008 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 06/16/2005 | US20050131002 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
| 06/16/2005 | US20050131001 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130976 Bicyclic inhibitors of MEK and methods of use thereof |